Mark Coleman, Director: Axsome Therapeutics AXSM Sell · Filed 24/05/29

Trade details

Type: Insider sale
Amount: $394,777.29
Shares · price: 5,249 sh · $75.21 a share
Held after: 19,848 sh
Stock: Axsome Therapeutics AXSM
Person: Mark ColemanDirector
Trade date: 24/05/28
Filed: 24/05/29
Days to filing: 1 days

Sold 20.9% of holdings

Share of holding sold: 20.9%

Axsome Therapeutics trades, last 26 weeks

What else happened in Axsome Therapeutics around then

Filed or reported within 30 days of the trade day · 24/04/28~24/06/27

Mark Coleman's recent trades

Mark ColemanDirector
Sell10b5-1 planAxsome Therapeutics
Sell10b5-1 plan
Axsome Therapeutics
AXSM
$160.1K
643 sh
$160.1K
Filed 06/10
Traded 06/10
Mark ColemanDirector
Planned sale10b5-1 planAxsome Therapeutics
Planned sale10b5-1 plan
Axsome Therapeutics
AXSM
$160.1K
643 sh
$160.1K
Filed 06/10
Traded 06/10
Mark ColemanDirector
Sell10b5-1 planAxsome Therapeutics
Sell10b5-1 plan
Axsome Therapeutics
AXSM
$1.4M
6,000 sh
$1.4M
Filed 06/02
Traded 05/29
Mark ColemanDirector
Sell10b5-1 planAxsome Therapeutics
Sell10b5-1 plan
Axsome Therapeutics
AXSM
$1.4M
6,000 sh
$1.4M
Filed 06/02
Traded 06/01
Mark ColemanDirector
Sell10b5-1 planAxsome Therapeutics
Sell10b5-1 plan
Axsome Therapeutics
AXSM
$1.2M
5,537 sh
$1.2M
Filed 06/02
Traded 06/02

Mark Coleman, Director — sold $394.8K of Axsome Therapeutics AXSM · 20.9% of holdings · 10b5-1 plan | Whalegun